111In-Pentetreotide Uptake Due to COVID-19 Vaccination

Clin Nucl Med. 2022 Mar 1;47(3):271-272. doi: 10.1097/RLU.0000000000003935.

Abstract

A 72-year-old woman was referred for whole-body 111In-pentetreotide scintigraphy with SPECT/CT. There was increased uptake of lymphadenopathy in the left axilla and left deltoid muscle. The patient's history revealed that the patient received the first dose of the COVID-19 vaccine 3 days before the 111In-pentetreotide scintigraphy with SPECT/CT. This case demonstrates that the COVID-19 vaccine can cause 111In-pentetreotide uptake in the lymph nodes and the deltoid muscle.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • COVID-19
  • COVID-19 Vaccines*
  • Deltoid Muscle / metabolism
  • Female
  • Humans
  • Indium Radioisotopes / metabolism*
  • Lymph Nodes / metabolism
  • Somatostatin / analogs & derivatives
  • Somatostatin / metabolism*
  • Tomography, X-Ray Computed
  • Vaccination

Substances

  • COVID-19 Vaccines
  • Indium Radioisotopes
  • Somatostatin
  • Indium-111
  • pentetreotide